Anti-Depressants

Vilazodone (Viibryd) 30 Tablets

$69.00

1. Treatment for Major Depressive Disorder: Viibryd is indicated for the treatment of major depressive disorder, a mental health condition characterized by persistent feelings of sadness, loss of interest or pleasure, and other emotional and physical symptoms.
2. Oral Tablet Formulation: Vilazodone is available in tablet form for oral administration, providing a convenient and easily dosed treatment option.

Strength	Choose an option2040
	Clear

Quantity

Vilazodone (Viibryd) 30 Tablets quantity

Add to cart

Sku:

N/A

Description

Vilazodone, marketed under the brand name Viibryd, is a medication primarily used for the treatment of major depressive disorder (MDD). It belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs) and serotonin receptor agonists. Here’s a detailed overview of its key features, proper usage instructions, precautions, and potential side effects:

Key Features:

1. SSRI and Serotonin Receptor Agonist: Vilazodone works by inhibiting the reuptake of serotonin, a neurotransmitter in the brain associated with mood regulation, and by acting as a partial agonist at serotonin receptors, enhancing serotonin activity.
2. Treatment for Major Depressive Disorder: Viibryd is indicated for the treatment of major depressive disorder, a mental health condition characterized by persistent feelings of sadness, loss of interest or pleasure, and other emotional and physical symptoms.
3. Oral Tablet Formulation: Vilazodone is available in tablet form for oral administration, providing a convenient and easily dosed treatment option.
4. Unique Mechanism of Action: Viibryd’s dual mechanism of action, targeting both serotonin reuptake inhibition and serotonin receptor modulation, may offer advantages in terms of efficacy and tolerability compared to traditional SSRIs.

Usage Instructions:

• Vilazodone tablets are typically taken orally, with or without food, once daily.
• The recommended starting dosage for adults is usually 10 mg daily for the first week, followed by an increase to the target maintenance dosage of 20 mg daily.
• The dosage may be further increased to 40 mg daily based on individual response and tolerability, as determined by your healthcare provider.
• Swallow the tablet whole with water, without chewing or crushing it.
• It may take several weeks for Vilazodone to exert its full therapeutic effects, so continue taking the medication as prescribed, even if you do not immediately feel better.

Precautions:

• Before starting Vilazodone treatment, inform your healthcare provider about any existing medical conditions, especially if you have a history of bipolar disorder, seizures, liver or kidney disease, or if you are pregnant or breastfeeding.
• Vilazodone may interact with other medications, including monoamine oxidase inhibitors (MAOIs), triptans, or certain antidepressants. Inform your doctor about all medications you are taking to avoid potential drug interactions.
• Avoid abruptly discontinuing Vilazodone, as this may lead to withdrawal symptoms such as dizziness, headache, nausea, or irritability. Your healthcare provider may gradually taper the dosage to minimize withdrawal effects.

Side Effects:

• Common side effects of Vilazodone may include diarrhea, nausea, vomiting, dizziness, dry mouth, or insomnia. These symptoms are usually mild and temporary, and may improve over time as your body adjusts to the medication.
• Less common but more serious side effects may include suicidal thoughts or behavior, serotonin syndrome (characterized by agitation, hallucinations, fever, sweating, tremors, or rapid heart rate), or allergic reactions. Seek medical attention immediately if you experience any severe or unusual symptoms.

It’s essential to discuss the risks and benefits of Vilazodone treatment with your healthcare provider, especially if you have any underlying medical conditions or are taking other medications. Adhering to the prescribed dosage and usage instructions can help maximize the effectiveness of Viibryd while minimizing the risk of adverse effects.

Additional information